Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D PITTMAN

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Blood|January 15, 1992
A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavageD D Pittman, M Millenson, K Marquette, et al.
Cognition & Emotion|October 15, 2013
When do self-discrepancies predict negative emotions? Exploring formal operational thought and abstract reasoning skills as moderatorsErin N Stevens, Nicole J Holmberg, M Christine Lovejoy, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|September 8, 2011
A possible method to predict response to non-pharmacological insomnia therapyLisa M Campana, Gari D Clifford, John Trinder, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1987
Postgraduate training in radiation oncology in the United States, 1986J D Cox, D F Flynn, D D Pittman, et al.
Biochemistry|June 7, 1994
Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activityD D Pittman, K N Tomkinson, D Michnick, et al.
Sleep|February 3, 2005
A novel adaptive wrist actigraphy algorithm for sleep-wake assessment in sleep apnea patientsJan Hedner, Giora Pillar, Stephen D Pittman, et al.
The Journal of Biological Chemistry|November 15, 1991
The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIIIR J Wise, A J Dorner, M Krane, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 27, 2010
Phase-rectified signal averaging as a sensitive index of autonomic changes with agingL M Campana, R L Owens, G D Clifford, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2017
Phase 1 dose-escalating study to evaluate the safety, pharmacokinetics, and pharmacodynamics of a recombinant factor Xa variant (FXa<sup>I16L</sup> )D Parsons-Rich, F Hua, G Li, et al.
Research and Practice in Thrombosis and Haemostasis|November 17, 2025
Marstacimab, an antitissue factor pathway inhibitor, combined with bypassing agents: effects on thrombin generation and in hemostatically normal ratsMarjorie A Peraza, Swapnil Rakhe, Susan Hurst, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Blood|January 15, 1992
A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavageD D Pittman, M Millenson, K Marquette, et al.
Cognition & Emotion|October 15, 2013
When do self-discrepancies predict negative emotions? Exploring formal operational thought and abstract reasoning skills as moderatorsErin N Stevens, Nicole J Holmberg, M Christine Lovejoy, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|September 8, 2011
A possible method to predict response to non-pharmacological insomnia therapyLisa M Campana, Gari D Clifford, John Trinder, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1987
Postgraduate training in radiation oncology in the United States, 1986J D Cox, D F Flynn, D D Pittman, et al.
Biochemistry|June 7, 1994
Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activityD D Pittman, K N Tomkinson, D Michnick, et al.
Sleep|February 3, 2005
A novel adaptive wrist actigraphy algorithm for sleep-wake assessment in sleep apnea patientsJan Hedner, Giora Pillar, Stephen D Pittman, et al.
The Journal of Biological Chemistry|November 15, 1991
The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIIIR J Wise, A J Dorner, M Krane, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 27, 2010
Phase-rectified signal averaging as a sensitive index of autonomic changes with agingL M Campana, R L Owens, G D Clifford, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2017
Phase 1 dose-escalating study to evaluate the safety, pharmacokinetics, and pharmacodynamics of a recombinant factor Xa variant (FXa<sup>I16L</sup> )D Parsons-Rich, F Hua, G Li, et al.
Research and Practice in Thrombosis and Haemostasis|November 17, 2025
Marstacimab, an antitissue factor pathway inhibitor, combined with bypassing agents: effects on thrombin generation and in hemostatically normal ratsMarjorie A Peraza, Swapnil Rakhe, Susan Hurst, et al.
Pageof 11